Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 20/20 | 0.64 |
| ▸ | F10 | P00742 | 1/20 | 0.57 |
| ▸ | PROC | P04070 | 1/20 | 0.57 |
| ▸ | F7 | P08709 | 1/20 | 0.57 |
| ▸ | MASP2 | O00187 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Melagatran SCHEMBL23840802 | 1.00 | F2 (0.64) | F2F10PROCF7MASP2 | |
| Melagatran SCHEMBL8083301 | 1.00 | F2 (0.64) | F2F10PROCF7MASP2 | |
| Melagatran SCHEMBL20567754 | 1.00 | F2 (0.64) | F2F10PROCF7MASP2 | |
| Melagatran SCHEMBL5706395 | 0.99 | F2 (0.63) | F2F10PROCF7MASP2 | |
| Melagatran SCHEMBL3209070 | 0.99 | F2 (0.63) | F2F10PROCF7MASP2 | |
| Melagatran SCHEMBL27557537 | 0.99 | F2 (0.63) | F2F10PROCF7MASP2 | |
| Melagatran SCHEMBL29160734 | 0.99 | F2 (0.63) | F2F10PROCF7MASP2 | |
| SCHEMBL23793366 | 0.99 | F2 (0.62) | F2F10PROCF7MASP2 | |
| SCHEMBL23840808 | 0.95 | F2 (0.64) | F2F10PROCF7 | |
| SCHEMBL23840772 | 0.95 | F2 (0.64) | F2F10PROCF7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6142 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075463-A | Pharmaceutical composition containing melagatran besylate and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075429-A | 20Mg core-pressed or core-shell type biphasic release tablet containing mezloballin or pharmaceutically acceptable salt thereof and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122005480-A | Meloxepin besylate tablet and preparation method thereof | 山东鲁抗医药股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12605371-B2 | Combination therapy for cancer | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-04-21 | — | — | US | claimed |
| US-12521258-B2 | Anticoagulant compounds and methods and devices for their use | ELIXIR MEDICAL CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| WO-2025262269-A1 | MONITORING OF REVERSAL AGENTS FOR ANTICOAGULANTS | ENZYRE B.V. (NL) | 2025-12-26 | — | — | WO | claimed |
| EP-4658806-A1 | DISPOSABLE CARTRIDGE FOR CLASSIFICATION OF ANTICOAGULANT AND METHOD OF USE | Haemonetics Corporation (US) | 2025-12-10 | — | — | EP | claimed |
| US-20250347706-A1 | DISPOSABLE CARTRIDGE FOR CLASSIFICATION OF ANTICOAGULANT AND METHOD OF USE | HAEMONETICS CORP (US) | 2025-11-13 | — | — | US | claimed |
| EP-3787631-B1 | MODULATORS OF ORPHAN NUCLEAR RECEPTORS FOR NASH AND OTHER METABOLIC DISORDERS | UNIV EMORY (US) | 2025-09-10 | — | — | EP | claimed |
| CN-120131636-A | Twin medicine and composition and application thereof | 江苏海洋大学 | 2025-06-13 | — | — | CN | claimed |
| EP-0942960-A1 | PROMOTION OF REGENERATION OF ORGANIZED TISSUES | Hansson, Hans-Arne (SE) | 1999-09-22 | — | — | EP | claimed |
| CN-1219965-A | Promoting regeneration of organotypic tissue | HANS ARNE HANSSON (SE) | 1999-06-16 | — | — | CN | claimed |
| WO-1999027913-A1 | POLYETHYLENE GLYCOL MATRIX PELLETS FOR GREASY, OILY OR STICKY DRUG SUBSTANCES | ASTRAZENECA AB (SE) | 1999-06-10 | — | — | WO | claimed |
| WO-1999027912-A1 | POROUS HYDROXYAPATITE PARTICLES AS CARRIERS FOR DRUG SUBSTANCES | ASTRAZENECA AB (SE) | 1999-06-10 | — | — | WO | claimed |
| CN-1213309-A | Control of healing process | HANSSON HANS ARNE (SE) | 1999-04-07 | — | — | CN | claimed |
| EP-0874634-A1 | CONTROL OF HEALING PROCESS | Hansson, Hans-Arne (SE) | 1998-11-04 | — | — | EP | claimed |
| WO-1998016252-A1 | NEW PHARMACEUTICAL PARENTERAL FORMULATION OF A THROMBIN INHIBITOR | ASTRA AKTIEBOLAG (SE) | 1998-04-23 | — | — | WO | claimed |
| WO-1997039770-A1 | NEW PHARMACEUTICAL FORMULATION OF A THROMBIN INHIBITOR FOR PARENTERAL USE | ASTRA AKTIEBOLAG (SE) | 1997-10-30 | — | — | WO | claimed |
| WO-1997037002-A1 | PROMOTION OF REGENERATION OF ORGANIZED TISSUES | HANSSON HANS ARNE (SE) | 1997-10-09 | — | — | WO | claimed |
| WO-1997025994-A1 | CONTROL OF HEALING PROCESS | HANSSON HANS ARNE (SE) | 1997-07-24 | — | — | WO | claimed |